Cogent Biosciences Ownership 2024 | Who Owns Cogent Biosciences Now?
Institutional Ownership
8.63%
Insider Ownership
0.13%
Retail Ownership
91.25%
Institutional Holders
43.00
Cogent Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 15.10% | 0.33% | 14,986,398 | 8,310,150 | 124.47% | 126,335,335 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 9.81% | 5.60% | 9,738,000 | 3,313,000 | 51.56% | 82,091,340 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 9.33% | 6.02% | 9,260,385 | 760,385 | 8.95% | 78,065,046 | Jun 30, 2024 |
| FMR LLC | 7.75% | 0.00% | 7,693,668 | 729,060 | 10.47% | 64,857,622 | Jun 30, 2024 |
| BLACKROCK INC. | 7.34% | 0.00% | 7,288,378 | 598,760 | 8.95% | 61,441,028 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 7.02% | 6.12% | 6,964,375 | 750,000 | 12.07% | 58,709,681 | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 6.27% | 5.93% | 6,225,641 | 1,500,000 | 31.74% | 52,482,154 | Jun 30, 2024 |
| VR ADVISER, LLC | 5.73% | 3.05% | 5,684,167 | 555,000 | 10.82% | 47,917,528 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.30% | 0.00% | 5,259,879 | -505,826 | -8.77% | 44,340,781 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 4.84% | 2.45% | 4,799,973 | 837,371 | 21.13% | 40,463,772 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.28% | 0.07% | 4,248,888 | 2,915,555 | 218.67% | 35,818,126 | Jun 30, 2024 |
| STATE STREET CORP | 3.87% | 0.00% | 3,836,962 | -3,789,907 | -49.69% | 32,345,590,000 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.77% | 0.53% | 3,744,263 | 2,209,918 | 144.03% | 31,564,137 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 3.65% | 1.17% | 3,624,342 | 3,624,342 | 100.00% | 30,553,203 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 2.79% | 1.22% | 2,773,286 | 372,515 | 15.52% | 23,378,801 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 2.26% | 1.75% | 2,244,941 | - | - | 18,924,853 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.00% | 0.00% | 1,980,731 | 203,627 | 11.46% | 16,700,791 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 1.69% | 5.33% | 1,673,919 | 78,898 | 4.95% | 14,111,137 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.41% | 0.20% | 1,398,992 | 1,398,992 | 100.00% | 11,793,503 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.24% | 0.00% | 1,231,857 | -1,124,069 | -47.71% | 10,384,555 | Jun 30, 2024 |
Cogent Biosciences's largest institutional shareholder is POINT72 ASSET MANAGEMENT, L.P., holding 15.10% of the company's total share outstanding, currently valued at $126.34M. The top 10 institutional shareholders own together 78.50% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | 7.02% | 6.12% | 6,964,375 | 750,000 | 12.07% | 58,709,681 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 9.33% | 6.02% | 9,260,385 | 760,385 | 8.95% | 78,065,046 | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 6.27% | 5.93% | 6,225,641 | 1,500,000 | 31.74% | 52,482,154 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 9.81% | 5.60% | 9,738,000 | 3,313,000 | 51.56% | 82,091,340 | Jun 30, 2024 |
| SATURN V CAPITAL MANAGEMENT LLC | 1.69% | 5.33% | 1,673,919 | 78,898 | 4.95% | 14,111,137 | Jun 30, 2024 |
| VR ADVISER, LLC | 5.73% | 3.05% | 5,684,167 | 555,000 | 10.82% | 47,917,528 | Jun 30, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 0.25% | 2.57% | 250,765 | - | - | 2,113,949 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 4.84% | 2.45% | 4,799,973 | 837,371 | 21.13% | 40,463,772 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.22% | 2.40% | 1,206,214 | 169,547 | 16.36% | 10,168,384 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 2.26% | 1.75% | 2,244,941 | - | - | 18,924,853 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 0.80% | 1.49% | 790,440 | - | - | 6,663,409 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.50% | 1.26% | 500,000 | -55,500 | -9.99% | 4,215,000 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 2.79% | 1.22% | 2,773,286 | 372,515 | 15.52% | 23,378,801 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 3.65% | 1.17% | 3,624,342 | 3,624,342 | 100.00% | 30,553,203 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.28% | 0.87% | 281,093 | - | - | 2,369,614 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.77% | 0.53% | 3,744,263 | 2,209,918 | 144.03% | 31,564,137 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.80% | 0.39% | 790,936 | - | - | 6,667,590 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 0.94% | 0.37% | 936,576 | - | - | 7,895,336 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.01% | 0.36% | 1,000,706 | 555,000 | 124.52% | 8,435,952 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 15.10% | 0.33% | 14,986,398 | 8,310,150 | 124.47% | 126,335,335 | Jun 30, 2024 |
The largest Cogent Biosciences shareholder by % of total assets is TCG CROSSOVER MANAGEMENT, LLC. The company owns 6.96M shares of Cogent Biosciences (COGT), representing 6.12% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 15.10% | 0.33% | 14,986,398 | 8,310,150 | 124.47% | 126,335,335 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 3.65% | 1.17% | 3,624,342 | 3,624,342 | 100.00% | 30,553,203 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 9.81% | 5.60% | 9,738,000 | 3,313,000 | 51.56% | 82,091,340 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.28% | 0.07% | 4,248,888 | 2,915,555 | 218.67% | 35,818,126 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.77% | 0.53% | 3,744,263 | 2,209,918 | 144.03% | 31,564,137 | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 6.27% | 5.93% | 6,225,641 | 1,500,000 | 31.74% | 52,482,154 | Jun 30, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.41% | 0.20% | 1,398,992 | 1,398,992 | 100.00% | 11,793,503 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.01% | 0.00% | 1,000,116 | 1,000,116 | 100.00% | 8,430,978 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 4.84% | 2.45% | 4,799,973 | 837,371 | 21.13% | 40,463,772 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 9.33% | 6.02% | 9,260,385 | 760,385 | 8.95% | 78,065,046 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 7.02% | 6.12% | 6,964,375 | 750,000 | 12.07% | 58,709,681 | Jun 30, 2024 |
| FMR LLC | 7.75% | 0.00% | 7,693,668 | 729,060 | 10.47% | 64,857,622 | Jun 30, 2024 |
| BLACKROCK INC. | 7.34% | 0.00% | 7,288,378 | 598,760 | 8.95% | 61,441,028 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.01% | 0.36% | 1,000,706 | 555,000 | 124.52% | 8,435,952 | Jun 30, 2024 |
| VR ADVISER, LLC | 5.73% | 3.05% | 5,684,167 | 555,000 | 10.82% | 47,917,528 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 2.79% | 1.22% | 2,773,286 | 372,515 | 15.52% | 23,378,801 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.00% | 0.00% | 1,980,731 | 203,627 | 11.46% | 16,700,791 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | 0.74% | 0.20% | 734,197 | 196,997 | 36.67% | 6,189,281 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.22% | 2.40% | 1,206,214 | 169,547 | 16.36% | 10,168,384 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.15% | 0.02% | 148,854 | 130,001 | 689.55% | 1,254,839 | Jun 30, 2024 |
As of Jun 30 2024, Cogent Biosciences's largest institutional buyer is POINT72 ASSET MANAGEMENT, L.P.. The company purchased 8.31M stocks of COGT, valued at $126.34M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 3.87% | 0.00% | 3,836,962 | -3,789,907 | -49.69% | 32,345,590,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 0.02% | 0.00% | 15,773 | -2,083,584 | -99.25% | 132,809 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.24% | 0.00% | 1,231,857 | -1,124,069 | -47.71% | 10,384,555 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -883,333 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.99% | 0.00% | 981,644 | -869,072 | -46.96% | 8,275,261 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.19% | 0.01% | 183,963 | -520,897 | -73.90% | 1,550,808 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.30% | 0.00% | 5,259,879 | -505,826 | -8.77% | 44,340,781 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.94% | 0.00% | 930,297 | -463,901 | -33.27% | 7,842,422 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -450,000 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.52% | 0.00% | 513,747 | -357,450 | -41.03% | 4,330,887 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | - | - | - | -316,000 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.13% | 0.00% | 126,539 | -304,466 | -70.64% | 1,066,724 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -299,668 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.77% | 0.00% | 764,347 | -257,744 | -25.22% | 6,443,446 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.46% | 0.08% | 459,938 | -245,693 | -34.82% | 3,877,277 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.16% | 0.04% | 157,034 | -207,078 | -56.87% | 1,324,000 | Jun 30, 2024 |
| SECTORAL ASSET MANAGEMENT INC | 0.09% | 0.29% | 85,600 | -178,100 | -67.54% | 721,608 | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -167,878 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.30% | 0.00% | 298,711 | -152,521 | -33.80% | 2,518,134 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -123,017 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Cogent Biosciences's biggest institutional seller is STATE STREET CORP. The company sold -3.79M shares of COGT, valued at $32.35B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 3.65% | 1.17% | 3,624,342 | 3,624,342 | 100.00% | 30,553,203 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.01% | 0.00% | 1,000,116 | 1,000,116 | 100.00% | 8,430,978 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.13% | 0.06% | 127,712 | 127,712 | 100.00% | 1,076,612 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.08% | 0.00% | 74,598 | 74,598 | 100.00% | 628,861 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 49,367 | 49,367 | 100.00% | 416,164 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 49,228 | 49,228 | 100.00% | 415,061 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.04% | 0.00% | 44,441 | 44,441 | 100.00% | 374,638 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.02% | 0.00% | 22,559 | 22,559 | 100.00% | 190,173 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.01% | 0.00% | 13,612 | 13,612 | 100.00% | 114,749 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.01% | 0.05% | 12,162 | 12,162 | 100.00% | 102,526 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.01% | - | 12,005 | 12,005 | 100.00% | 101,202 | Jun 30, 2024 |
| COLONY GROUP, LLC | 0.01% | 0.00% | 11,628 | 11,628 | 100.00% | 98,000 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.01% | 10,561 | 10,561 | 100.00% | 89,029 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,786 | 1,786 | 100.00% | 15,056 | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | 0.00% | 0.00% | 376 | 376 | 100.00% | 3,170 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 273 | 273 | 100.00% | 2,304 | Jun 30, 2024 |
| US BANCORP \DE\ | 0.00% | - | 137 | 137 | 100.00% | 1,155 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 86 | 86 | 100.00% | 725 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.00% | - | 70 | 70 | 100.00% | 590 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | - | - | 28 | 28 | 100.00% | 237 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | 1 | 1 | 100.00% | 8,000 | Jun 30, 2024 |
Cogent Biosciences's largest new institutional shareholder by number of shares is PARADIGM BIOCAPITAL ADVISORS LP, purchased 3.62M shares, valued at $30.55M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | - | - | - | -883,333 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -450,000 | -100.00% | - | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | - | - | - | -316,000 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -299,668 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -167,878 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -123,017 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -61,111 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -40,935 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -39,800 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -32,851 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -31,292 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -22,442 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | - | - | - | -17,822 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -16,843 | -100.00% | - | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | - | - | - | -16,744 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -15,808 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -14,750 | -100.00% | - | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -11,470 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -7,303 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,461 | -100.00% | - | Jun 30, 2024 |
| QUARRY LP | - | - | - | -1,500 | -100.00% | - | Jun 30, 2024 |
| QUADRANT CAPITAL GROUP LLC | - | - | - | -689 | -100.00% | - | Jun 30, 2024 |
| YHB INVESTMENT ADVISORS, INC. | - | - | - | -50 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -16 | -100.00% | - | Jun 30, 2024 |
Cogent Biosciences's largest sold out institutional shareholder by shares sold is PERCEPTIVE ADVISORS LLC, sold -0.88M shares, valued at -, as of undefined.
Cogent Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA HEALTHCARE INVESTORS | 0.43% | 368,960 | - | - | Mar 31, 2024 |
| Tema ETF Trust | 0.40% | 18,032 | 5,096 | 39.39% | Feb 29, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.31% | 146,911 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.20% | 230,000 | - | - | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.14% | 1,198,600 | 194,200 | 19.33% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.11% | 55,453 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.03% | 738 | 233 | 46.14% | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 149,681 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.02% | 268,225 | 180,054 | 204.21% | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 12,569 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 16,545 | 8,845 | 114.87% | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 24,751 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,520,974 | -273,147 | -5.70% | Mar 31, 2024 |
| North Square Investments Trust | 0.01% | 98,480 | 64,450 | 189.39% | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 68,109 | - | - | Mar 28, 2024 |
| TIAA-CREF LIFE FUNDS | 0.01% | 17,717 | 16,630 | 1529.90% | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 582,475 | -2,335,925 | -80.04% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 68,925 | -431,275 | -86.22% | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 40,414 | 11,920 | 41.83% | Aug 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.01% | 228,757 | 3,273 | 1.45% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,061 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 309,337 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 46,369 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 723,254 | 5,052 | 0.70% | Feb 29, 2024 |
| ProFunds | 0.00% | 36,405 | 19,527 | 115.69% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 8,129 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 20,647 | -26,788 | -56.47% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 65,793 | 11,425 | 21.01% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 391,400 | - | - | Feb 29, 2024 |
| BRIDGEWAY FUNDS INC | 0.00% | 4,690 | - | - | Mar 28, 2024 |
| Direxion Shares ETF Trust | 0.00% | 277,162 | 126,584 | 84.07% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 20,752 | 446 | 2.20% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 6,525 | - | - | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 40,533 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,246,402 | 195,946 | 18.65% | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 65,800 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 17,724 | -203 | -1.13% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 212,187 | 31,029 | 17.13% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 27,320 | -5,476 | -16.70% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 367,351 | -77,313 | -17.39% | Jan 31, 2024 |
| Global X Funds | 0.00% | 36,487 | 8,488 | 30.32% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 9,477 | -602 | -5.97% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,794 | -469 | -11.00% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 16,663 | 533 | 3.30% | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 16,165 | 16,165 | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 397,615 | 22,847 | 6.10% | Feb 29, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 2,232,968 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 26,275 | 14,342 | 120.19% | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 4,914 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 50,813 | -164 | -0.32% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 27,900 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 43,606 | -3,843 | -8.10% | Mar 28, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 2,732 | 2,732 | - | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 3,714,548 | -27,726 | -0.74% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 374,121 | 51,578 | 15.99% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 213,003 | -5,739 | -2.62% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 22,957 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 716 | - | - | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 5,872,565 | 3,296,718 | 127.99% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 31,877 | 628 | 2.01% | Feb 29, 2024 |
| VALIC Co I | 0.00% | 30,000 | - | - | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 46,643 | 5,749 | 14.06% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,900 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 365 | - | - | Dec 31, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 7,752 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 10,774 | -94 | -0.86% | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 7,731 | - | - | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 1,840 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 18,606 | 2,674 | 16.78% | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 196,371 | - | - | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,889 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 3,141 | 1,237 | 64.97% | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 19,161 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 48 | - | - | Dec 31, 2023 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 118,400 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 9,252 | 1,645 | 21.62% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 221 | - | - | Feb 29, 2024 |
| Pacer Funds Trust | 0.00% | 1,577 | 27 | 1.74% | Jan 31, 2024 |
| RBB FUND, INC. | 0.00% | 3,116 | - | - | Feb 29, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 73,645 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 77,866 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 27,046 | -213 | -0.78% | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,730 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 9,411 | 186 | 2.02% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 1,457 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 22,858 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 31,131 | 448 | 1.46% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 50,265 | 2,115 | 4.39% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 221 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 1,100 | 1,100 | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 31,430 | 1,951 | 6.62% | Mar 31, 2024 |
| AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.00% | 124,411 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 26,388 | 20,283 | 332.24% | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 2,279 | 778 | 51.83% | Feb 29, 2024 |
| Legg Mason Global Asset Management Trust | 0.00% | 53,600 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 396 | - | - | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 23,655 | 668 | 2.91% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,882 | - | - | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 10,042 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 204 | 62 | 43.66% | Jan 31, 2024 |
Cogent Biosciences's largest mutual fund holder by % of total assets is "TEKLA HEALTHCARE INVESTORS", owning 368.96K shares, compromising 0.43% of its total assets.
Cogent Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 43 | -72.44% |
| 31 Mar, 24 | 156 | 4.70% |
| 31 Dec, 23 | 149 | 7.97% |
| 30 Sep, 23 | 138 | 0.73% |
| 30 Jun, 23 | 137 | 0.74% |
| 31 Mar, 23 | 136 | - |
| 31 Dec, 22 | 136 | 0.74% |
| 30 Sep, 22 | 135 | 15.38% |
| 30 Jun, 22 | 117 | 37.65% |
| 31 Mar, 22 | 85 | 6.25% |
| 31 Dec, 21 | 80 | 9.59% |
| 30 Sep, 21 | 73 | 8.96% |
| 30 Jun, 21 | 67 | - |
| 31 Mar, 21 | 67 | - |
| 31 Dec, 20 | 67 | - |
As of 30 Jun 24, 43 institutions are holding Cogent Biosciences's shares, representing a decrease of -72.44% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 8,559,729 | -92.17% |
| 31 Mar, 24 | 109,251,854 | 20.30% |
| 31 Dec, 23 | 90,815,313 | -0.05% |
| 30 Sep, 23 | 90,861,407 | 2.34% |
| 30 Jun, 23 | 88,785,304 | 17.96% |
| 31 Mar, 23 | 75,268,528 | 0.53% |
| 31 Dec, 22 | 74,869,527 | 0.65% |
| 30 Sep, 22 | 74,389,091 | 5.82% |
| 30 Jun, 22 | 70,296,685 | 48.87% |
| 31 Mar, 22 | 47,220,030 | 5.17% |
| 31 Dec, 21 | 44,899,427 | 22.02% |
| 30 Sep, 21 | 36,797,725 | 1.12% |
| 30 Jun, 21 | 36,389,476 | 5.58% |
| 31 Mar, 21 | 34,467,478 | 2.89% |
| 31 Dec, 20 | 33,499,429 | - |
Cogent Biosciences (COGT) has 8.56M shares outstanding as of 30 Jun 24, down -92.17% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 8.63% | 0.06% |
| 31 Mar, 24 | 115.24% | 1.05% |
| 31 Dec, 23 | 104.71% | 0.94% |
| 30 Sep, 23 | 105.45% | 0.75% |
| 30 Jun, 23 | 118.77% | 1.05% |
| 31 Mar, 23 | 106.41% | 0.94% |
| 31 Dec, 22 | 106.21% | 0.93% |
| 30 Sep, 22 | 106.92% | 0.53% |
| 30 Jun, 22 | 142.33% | 1.30% |
| 31 Mar, 22 | 104.69% | 0.78% |
| 31 Dec, 21 | 115.93% | 1.36% |
| 30 Sep, 21 | 92.34% | 1.03% |
| 30 Jun, 21 | 94.66% | 0.97% |
| 31 Mar, 21 | 98.82% | 0.32% |
| 31 Dec, 20 | 175.50% | - |
As of 30 Jun 24, Cogent Biosciences is held by 8.63% institutional shareholders, representing a 0.06% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 19 | -80.81% |
| 31 Mar, 24 | 99 | 2.06% |
| 31 Dec, 23 | 97 | 38.57% |
| 30 Sep, 23 | 70 | -10.26% |
| 30 Jun, 23 | 78 | 34.48% |
| 31 Mar, 23 | 58 | -21.62% |
| 31 Dec, 22 | 74 | -2.63% |
| 30 Sep, 22 | 76 | -6.17% |
| 30 Jun, 22 | 81 | 145.45% |
| 31 Mar, 22 | 33 | -15.38% |
| 31 Dec, 21 | 39 | 21.88% |
| 30 Sep, 21 | 32 | -11.11% |
| 30 Jun, 21 | 36 | -18.18% |
| 31 Mar, 21 | 44 | -34.33% |
| 31 Dec, 20 | 67 | - |
19 institutional shareholders have increased their position in COGT stock as of 30 Jun 24 compared to 99 in the previous quarter (a -80.81% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 15 | -57.14% |
| 31 Mar, 24 | 35 | 16.67% |
| 31 Dec, 23 | 30 | -14.29% |
| 30 Sep, 23 | 35 | -7.89% |
| 30 Jun, 23 | 38 | -15.56% |
| 31 Mar, 23 | 45 | 25.00% |
| 31 Dec, 22 | 36 | -5.26% |
| 30 Sep, 22 | 38 | 100.00% |
| 30 Jun, 22 | 19 | -36.67% |
| 31 Mar, 22 | 30 | 30.43% |
| 31 Dec, 21 | 23 | 21.05% |
| 30 Sep, 21 | 19 | 90.00% |
| 30 Jun, 21 | 10 | - |
| 31 Mar, 21 | 10 | - |
| 31 Dec, 20 | - | - |
15 institutional shareholders have reduced their position in COGT stock as of 30 Jun 24 compared to 35 in the previous quarter (a -57.14% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 43 | -72.44% | 8,559,729 | -92.17% | 8.63% | 0.06% | 19 | -80.81% | 15 | -57.14% |
| 31 Mar, 24 | 156 | 4.70% | 109,251,854 | 20.30% | 115.24% | 1.05% | 99 | 2.06% | 35 | 16.67% |
| 31 Dec, 23 | 149 | 7.97% | 90,815,313 | -0.05% | 104.71% | 0.94% | 97 | 38.57% | 30 | -14.29% |
| 30 Sep, 23 | 138 | 0.73% | 90,861,407 | 2.34% | 105.45% | 0.75% | 70 | -10.26% | 35 | -7.89% |
| 30 Jun, 23 | 137 | 0.74% | 88,785,304 | 17.96% | 118.77% | 1.05% | 78 | 34.48% | 38 | -15.56% |
| 31 Mar, 23 | 136 | - | 75,268,528 | 0.53% | 106.41% | 0.94% | 58 | -21.62% | 45 | 25.00% |
| 31 Dec, 22 | 136 | 0.74% | 74,869,527 | 0.65% | 106.21% | 0.93% | 74 | -2.63% | 36 | -5.26% |
| 30 Sep, 22 | 135 | 15.38% | 74,389,091 | 5.82% | 106.92% | 0.53% | 76 | -6.17% | 38 | 100.00% |
| 30 Jun, 22 | 117 | 37.65% | 70,296,685 | 48.87% | 142.33% | 1.30% | 81 | 145.45% | 19 | -36.67% |
| 31 Mar, 22 | 85 | 6.25% | 47,220,030 | 5.17% | 104.69% | 0.78% | 33 | -15.38% | 30 | 30.43% |
| 31 Dec, 21 | 80 | 9.59% | 44,899,427 | 22.02% | 115.93% | 1.36% | 39 | 21.88% | 23 | 21.05% |
| 30 Sep, 21 | 73 | 8.96% | 36,797,725 | 1.12% | 92.34% | 1.03% | 32 | -11.11% | 19 | 90.00% |
| 30 Jun, 21 | 67 | - | 36,389,476 | 5.58% | 94.66% | 0.97% | 36 | -18.18% | 10 | - |
| 31 Mar, 21 | 67 | - | 34,467,478 | 2.89% | 98.82% | 0.32% | 44 | -34.33% | 10 | - |
| 31 Dec, 20 | 67 | - | 33,499,429 | - | 175.50% | - | 67 | - | - | - |
Cogent Biosciences Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Cogent Biosciences's stock was made by Fairmount Funds Management LLC on Jun 12 2024, selling 1,500 shares at - per share (valued at -).
Cogent Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | - | - |
| Q2 2024 | 9 | 2 | 450.00% |
| Q1 2024 | 11 | 2 | 550.00% |
| Q4 2023 | 2 | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 9 | - | - |
| Q1 2023 | 7 | - | - |
| Q4 2022 | 2 | - | - |
| Q3 2022 | 4 | - | - |
| Q2 2022 | 15 | - | - |
| Q1 2022 | 7 | - | - |
| Q4 2021 | 3 | - | - |
| Q3 2021 | 2 | - | - |
| Q2 2021 | 3 | 2 | 150.00% |
| Q1 2021 | 16 | 1 | 1600.00% |
| Q4 2020 | 6 | - | - |
| Q3 2020 | 11 | 2 | 550.00% |
| Q2 2020 | 9 | 23 | 39.13% |
| Q1 2020 | 9 | - | - |
| Q4 2019 | 6 | - | - |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cogent Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | 1 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 1 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | 2 | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | 23 | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cogent Biosciences's stocks.
Cogent Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| ANAB | AnaptysBio, Inc. |
| OLMA | Olema Pharmaceuticals, Inc. |
| SANA | Sana Biotechnology, Inc. |
| IDYA | IDEAYA Biosciences, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| ZNTL | Zentalis Pharmaceuticals, Inc. |
| KALV | KalVista Pharmaceuticals, Inc. |
| KNSA | Kiniksa Pharmaceuticals, Ltd. |
| LRMR | Larimar Therapeutics, Inc. |
| MGTX | MeiraGTx Holdings plc |
| VTYX | Ventyx Biosciences, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| KROS | Keros Therapeutics, Inc. |
| MRSN | Mersana Therapeutics, Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
| KURA | Kura Oncology, Inc. |
| FIXX | Q32 Bio Inc. |
| LIFE | aTyr Pharma, Inc. |
| VRNA | Verona Pharma plc |
COGT Ownership FAQ
Who Owns Cogent Biosciences?
Cogent Biosciences is owned by institutional shareholders (8.63%), insiders (0.12%), and public (91.25%). The largest institutional shareholder of Cogent Biosciences is POINT72 ASSET MANAGEMENT, L.P. (15.10% of total shares) and the top mutual fund owner is TEKLA HEALTHCARE INVESTORS (0.43% of total shares).
Who are the major institutional shareholders of Cogent Biosciences?
Cogent Biosciences's major institutional shareholders are POINT72 ASSET MANAGEMENT, L.P., COMMODORE CAPITAL LP, KYNAM CAPITAL MANAGEMENT, LP, FMR LLC, and BLACKROCK INC.. The top five shareholders own together 49.34% of the company's share outstanding.
How many Cogent Biosciences shareholders are there?
As of Jun 2024, there are 43 institutional shareholders of Cogent Biosciences.
What percentage of Cogent Biosciences is owned by POINT72 ASSET MANAGEMENT, L.P?
POINT72 ASSET MANAGEMENT, L.P owns 14.99M shares of Cogent Biosciences, representing 15.10% of the company's total shares outstanding, valued at $126.34M (as of Jun 2024).
What percentage of Cogent Biosciences is owned by COMMODORE CAPITAL LP?
As of Jun 2024, COMMODORE CAPITAL LP holds 9.74M shares of Cogent Biosciences (COGT), compromising 9.81% of the company, valued at $82.09M.
What percentage of Cogent Biosciences is owned by KYNAM CAPITAL MANAGEMENT, LP?
KYNAM CAPITAL MANAGEMENT, LP is the third largest holder of Cogent Biosciences. The company owns 9.26M of the company's shares outstanding (worth $78.07M).